Herpes simplex virus type 1 encephalitis is associated with elevated levels of F 2 -isoprostanes and F 4 -neuroprostanes

References

• Adler H, Beland JL, Del-Pan NC, Kobzik L, Brewer JP, Martin TR, Rimm IJ (1997). Suppression of herpes sim-plex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, N052). J Exp Med 185: 1533–1540.
   PubMedGoogle Scholar
• Akaike T, Suga M, Maeda H (1998). Free radicals in viral pathogenesis: Molecular mechanisms involving super-oxide and NO. Proc Soc Ex Biol Med 217: 64–73.
   PubMed Web of Science ®Google Scholar
• Baringer JR, Pisani P (1994). Herpes simplex virus genomes in human nervous system tissues analyzed by polym-erase chain-reaction. Ann Neurol 36: 823–829.
   PubMed Web of Science ®Google Scholar
• Boven LA, Gomes L, Hery C, Gray F, Verhoef J, Portegies P, Tardieu M, Nottet HS (1999). Increased peroxynitrite ac-tivity in AIDS dementia complex: Implications for neu-ropathogenesis of HIV-1 infection. J Immonol 162: 4319–4327.
   PubMedGoogle Scholar
• Cabrera CV, Wohlenberg C, Openshaw H, Rey Mendez M, Puga A, Notkins AL (1980). Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature 288: 288–290.
   PubMed Web of Science ®Google Scholar
• Cantin EM, Hinton DR, Chen J, Openshaw H (1995). Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. 1 Virol 69: 4898–4905.
   PubMed Web of Science ®Google Scholar
• Chen SH, Garber DA, Schaffer PA, Knipe DM, Coen DM (2000). Persistent elevated expression of cytokine tran-scripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reacti-vation. Virology 278: 207–216.
   Google Scholar
• Croen D (1993). Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. Clin Invest 91: 2446–2452.
   Google Scholar
• Daheshia M, Kanangat S, Rouse BT (1998). Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res 67: 619–624.
   PubMed Web of Science ®Google Scholar
• Dobson CB, Itzhaki RF (1999). Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging 20: 457–465.
   PubMedGoogle Scholar
• Ellison D, Love S (1996). Acute viral infections. In Neu-ropathology. Ellison D, Love S (eds). Mosby (Harcourt Publishers Limited): London, pp 12.1-12.19.
   Google Scholar
• Feduchi E, Alonso MA, Carrasco L (1989). Human gamma interferon and tumor necrosis factor exert a synergis-tic blockade on the replication of herpes simplex virus. J Virol 63: 1354–1359.
   Google Scholar
• Fraser NW, Lawrence WC, Wroblewska Z, Gilden DH, Koprowski H (1981). Herpes simplex type 1 DNA in hu-man brain tissue. Proc Nat] Acad Sci USA 78: 6461–6465.
   PubMed Web of Science ®Google Scholar
• Fujii S, Akaike T, Maeda H (1999). Role of nitric oxide in the pathogenesis of herpes simplex virus encephalitis in rats. Virology 256: 203–212.
   PubMed Web of Science ®Google Scholar
• Fujioka N, Ohashi K, Ikeda M, Kurimoto M (2000). Autocrine intreferon-beta stimulation augments nitric oxide production by mouse macrophage J774A.1 cells infected with herpes simplex virus type 1. Microbiol Im-munol 44: 283–287.
   Google Scholar
• Geiger DK, Gurushanthaiah D, Howes EL, Lewandowski GA, Reed JC, Bloom FE, Sarvetnick NE (1995). Cytokine-mediated survival from lethal herpes simplex virus infection: Role of programmed neuronal death. Proc Nat] Acad Sci USA 92: 3411–3415.
   Google Scholar
• Geiger DK, Nash TC, Sawyer S, Krahl T, Patstone G, Reed JC, Krajewski S, Dalton D, Buchmeier MJ, Sarvetnick NE (1997). Interferon-y protects against herpes simplex virus type 1-mediated neuronal death. Virology 238: 189–197.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JM (1999). Free radicals in biology and medicine. 3rd ed. Oxford Univ Press: Oxford, UK.
   Google Scholar
• Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997). Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349: 241–244.
   PubMed Web of Science ®Google Scholar
• Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD (1993). Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Sci-ence 261: 1445–1448.
   PubMed Web of Science ®Google Scholar
• Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B (1993). In vivo expres-sion of inducible nitric oxide synthetase in experimen-tally induced neurologic diseases. Proc Nat] Acad Sci USA 90: 3024–3027.
   PubMed Web of Science ®Google Scholar
• Liedke W, Opalka B, Zimmermann CW, Lignitz E (1993). Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 116: 6–11.
   Google Scholar
• Lopez-Guerrero JA, Alonso MA (1997). Nitric oxide pro-duction induced by herpes simplex virus type 1 does not alter the course of the infection inhuman monocytic cells. I Gen Virol 78: 1977–1980.
   Google Scholar
• MacLean A, Wei XQ, Huang FP, Al-Alem UA, Chan WL, Liew FY (1998). Mice lacking inducible nitric-oxide syn-thase are more susceptible to herpes simplex virus in-fection despite enhanced Th1 cell responses. I Gen Virol 79: 825–830.
   PubMed Web of Science ®Google Scholar
• Meyding-Lamade U, Hass J, Lamade W, Stingele K, Kehm R, Fath A, Heinrich K, Storch Hagenlocher B, Wildemann B (1998). Herpes simplex virus encephalitis: Long-term comparative study of viral load and the expression of immunologic nitric-oxide synthetase in mouse brain tis-sue. Neurosci Lett 244: 9–12.
   PubMed Web of Science ®Google Scholar
• Matthews N, Neale ML, Jackson SK, Stark JM (1987). Tu-mour cell killing by tumour necrosis factor: Inhibition by anaerobic conditions, free radical scavengers and in-hibitors of arachidonate metabolism. Immunology 62: 153–155.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Roberts LJ (1997). The isoprostanes: Unique bioactive products of lipid peroxidation. Prog Lipid Res 36: 1–21.
   PubMed Web of Science ®Google Scholar
• Nucci C, Palamar a AT, Ciriolo MR, Nencioni L, Savini P, D'Agostini C, Rotilio G, Cerulli L, Garaci E (2000). Im-balance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply. Exp Eye Res 70: 215–220.
   Google Scholar
• Palu G, Biasolo MA, Sartor G, Masotti L, Papini E, Floreani M, Palatini P (1994). Effects of herpes simplex virus type 1 infection on the plasma membrane and related functions of HeL a S3 cells. I Gen Virol 75: 3337–3344.
   Google Scholar
• Patel M, Liang L, Roberts LJ (2001). Enhanced hippocam-pal F2 -isoprostane formation following kainate-induced seizures. I Neurochem 79: 1065–1069.
   PubMed Web of Science ®Google Scholar
• Pelosi E, Rozenberg F, Coen DM, Tyler KL (1998). A herpes simplex virus DNA polymerase mutation that specifi- cally attenuates neurovirulence in mice. Virology 252: 364–372.
   Google Scholar
• Peterhans E (1997a). Reactive oxygen species and nitric ox-ide in viral diseases. Biol Trace Elem Res 56: 107–116.
   PubMed Web of Science ®Google Scholar
• Peterhans E (1997b). Oxidants and antioxidants in viral diseases: Disease mechanisms and metabolic regulation. J Nutri 127: 962S–965S.
   Google Scholar
• Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD (1998). For-mation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. I Biol Chem 273: 13605–13612.
   Google Scholar
• Roizman B, Knipe DM (2001). Herpes simplex viruses and their replication. In Fields' Virology. Knipe DM, Howley PM (eds). Lippincott-Raven: Philadelphia, pp 2399–2460.
   Google Scholar
• Rossol-Voth R, Rossol S, Schut KH, Corridori S, deCian W, Falke D (1991). In vivo protective effect of tumour necro-sis factor alpha against experimental infection with her-pes simplex virus type 1.1 Gen Virol 72: 143–147.
   Google Scholar
• Sanchez-Alcazar JA, Schneider E, Martinez MA, Carmona P, Hernandez-Munoz I, Siles E, De La Torre P, Ruiz-Cabello J, Garcia I, Solis-Herruzo JA (2000). Tumor necrosis factor-alpha increases the steady-state reduc-tion of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem 275: 13353–13361.
   PubMed Web of Science ®Google Scholar
• Schultz P, Arbusow V, Strupp M, Dieterich M, Rauch E, Brandt T (1998). Highly variable distribution of HSV-1-specific DNA in human geniculate, vestibular and spiral ganglia. Neurosci Lett 252: 139–142.
   Google Scholar
• Schwarz KB (1996). Oxidative stress during viral infection: A review. Free Radic Biol Med 21: 641–649.
   PubMed Web of Science ®Google Scholar
• Shimeld C, Whiteland JL, Williams NA, Easty DL, Hill TJ (1997). Cytokine production in the nervous system of mice during acute and latent infection with herpes sim-plex virus type 1.1 Gen Virol 78: 3317–3325.
   Google Scholar
• Skoldenberg B (1996). Herpes simplex encephalitis. Scan I Infect Dis Suppl 100: 8–13.
   PubMedGoogle Scholar
• Steiner I (1996). Human herpesviruses latent infection in the nervous system. Immunol Rev 152: 157–173.
   PubMed Web of Science ®Google Scholar
• Steiner I, Modor N, Reibstein I, Spivack JG, Fraser NW (1994). Herpes simplex virus type 1 gene expression and reactivation of latent infection in the central nervous system. Neuropathol App] Neurobiol 20: 253–260.
   Google Scholar
• Valyi-Nagy T, Deshmane S, Dinner A, Fraser NW (1991). Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection and explantation of trigeminal ganglia. I Virol 65: 4142–4152.
   PubMed Web of Science ®Google Scholar
• Valyi-Nagy T, Deshmane SL, Raengsakulrach B, Nicosia M, Gesser RM, Wysocka M, Dinner A, Fraser NW (1992). Herpes simplex virus type 1 mutant in1814 establishes a unique, slowly progressing infection in SCID mice. Virol 66: 7336–7345.
   Google Scholar
• Valyi-Nagy T, Fareed MU, O'Keefe JS, Gesser RM, MacLean AR, Brown SM, Spivack JG, Fraser NW (1994). An HSV-1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice. I Gen Virol 75: 2059–2063.
   Google Scholar
• Valyi-Nagy T, Olson SJ, Valyi-Nagy K, Montine TJ, Dermody TS (2000). Herpes simplex virus type 1 latency in the murine nervous system is associated with oxida-tive damage to neurons. Virology 278: 309–321.
   PubMed Web of Science ®Google Scholar
• Valyi-Nagy T, Sidell K, Marnett LJ, Dermody TS, Roberts LJ, Morrow JD, Montine TJ (1999). Divergence of brain prostaglandin H synthetase activity and oxidative dam-age in mice with encephalitis. J Neuropathol Exp Neurol 58: 1269–1272.
   Google Scholar
• Wagner EK, Bloom DC (1997). Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 10: 419–434.
   PubMed Web of Science ®Google Scholar
• Whitley RJ (2001). Herpes simplex viruses. In Fields' Vi-rology. Knipe DM, Howley PM (eds). Lippincott-Raven Press: Philadelphia, pp 2461–2510.
   Google Scholar
• Wilt SG, Dugger NV, Hitt ND, Hoffman PM (2000). Evidence of oxidative damage in a murine leukemia virus-induced neurodegeneration. I Neurosci Res 62: 440–450.
   Google Scholar